Molecure – homepage
Logo of the National Centre for Research and Development (external link) Logo of the European Funds (external link)
Molecure
  • Home
  • About
    • About Molecure S.A.
    • Our Team
  • R&D
    • Pipeline
    • Targeting Unexplored Proteins
    • Publications
    • Posters
    • Research Partnerships
  • Patients
  • Investors & media
    • Investor Overview
    • Shareholder Information
    • Financial information
    • Investor Relations
    • News & events
  • Careers
    • Overview
    • Our Culture
    • Rewards & Benefits
    • Current Opportunities
  • Contact
    • Whistleblowers
  • PL
  • EN

Category: Posters

RNA Leaders Europe – Basel, Switzerland , March 15-16, 2023

EMBO Workshop, Cavtat, Croatia – September 9-13, 2022

EFMC, Nice, France – September 4-8, 2022

ESMO Congress, Paris, France – September 9-13, 2022

Discovery of small molecule compounds that modulate binding of YKL-40 with carbohydrates or galectin-3 as potential therapeutics for cancer I 37th ACS National Medicinal Chemistry Symposium, 26-29/06/2022 New York

Targeting Chi3l1 by a small molecule activates macrophages, June 15-17.2022, Lyon, France

Pharmacological inhibition of chitotriosidase (CHIT1) as a novel therapeutic approach for sarcoidosis I 12-16 June, 2022, Keystone, CO, USA

EFMC-ASMC’19 – September 1-5, 2019 | Athens, Greece

ACS National Meeting & Expo – August 25 – 29, 2019 | San Diego, CA

Posts navigation

Older posts
Newer posts
Molecure logo – Homepage

About us

Molecure is an innovative biotechnology company dedicated to discovering, developing and commercializing novel therapeutics for neoplastic and inflammatory diseases.
Facebook – external link X (Twitter) – external link LinkedIn – external link